COVID-19 vaccine safety surveillance Our work Main navigation National vaccine safety surveillance Active vaccine safety surveillance COVID-19 vaccine safety surveillance What is AusVaxSafety doing? How will AusVaxSafety monitor vaccine safety? Information for immunisation providers COVID-19 vaccine safety surveillance FAQ COVID-19 vaccine safety data Adverse event of special interest (AESI) long-term follow-up program Adverse Events Following Immunisation Clinical Assessment Network (AEFI-CAN) Vaccine safety in Australia AusVaxSafety summary report Publications AusVaxSafety is conducting national COVID-19 vaccine safety surveillance in Australia. This is to ensure ongoing safety of COVID-19 vaccines used in Australia to promote provider and public confidence in the vaccination program. Click on the tiles below to find out more. What is AusVaxSafety doing? AusVaxSafety is conducting active safety surveillance of COVID-19 vaccines in Australia. Find out more here. How does AusVaxSafety monitor vaccine safety? Find out how is AusVaxSafety monitoring COVID-19 vaccine safety here. Information for immunisation providers GPs/immunisation providers can get involved in monitoring COVID-19 vaccine safety. Find out more here. COVID-19 vaccine safety surveillance FAQ Answers to some of the frequently asked questions about COVID-19 vaccine safety surveillance in Australia. COVID-19 vaccine safety data COVID-19 vaccine safety results are available publicly. Find out more here. Our work Main navigation National vaccine safety surveillance Active vaccine safety surveillance COVID-19 vaccine safety surveillance What is AusVaxSafety doing? How will AusVaxSafety monitor vaccine safety? Information for immunisation providers COVID-19 vaccine safety surveillance FAQ COVID-19 vaccine safety data Adverse event of special interest (AESI) long-term follow-up program Adverse Events Following Immunisation Clinical Assessment Network (AEFI-CAN) Vaccine safety in Australia AusVaxSafety summary report Publications News & events All news & events 02 July 2024 | News Call for participants: new NCIRS study on possible links between genes and adverse events after COVID-19 vaccination 28 March 2024 | News AusVaxSafety commences routine surveillance of 2024 seasonal influenza vaccines 08 March 2024 | News Vaccine safety in Australia AusVaxSafety summary report now available 20 February 2024 | News What to expect in the days after your XBB.1.5 COVID-19 vaccine